MARZINE

Main information

  • Trade name:
  • MARZINE 50 mg tablet
  • Dosage:
  • 50 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription partly
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • MARZINE 50 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Cyclizine
  • Product summary:
  • Suitability for use in older adult patients Cyclizini hydrochloridum Avoid use in older persons. Anticholinergic. Sedative. Significant adverse effects include confusion, tiredness, xerostomia, constipation, dizziness, palpitations, urinary difficulties and risk for falls. Weakens the efficacy of anti-Alzheimer´s drugs.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 3882
  • Authorization date:
  • 19-11-2007
  • Last update:
  • 21-02-2018